Literature DB >> 24652023

Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer.

Wesley R McIlwain, Amit J Sood, Shaun A Nguyen, Terry A Day.   

Abstract

IMPORTANCE This study addresses the most common initial symptoms of oropharyngeal squamous cell carcinoma (OPSCC) and investigates differences between human papillomavirus (HPV)–positive vs HPV-negative tumors. OBJECTIVES To analyze the most common initial symptoms in patients with OPSCC and to determine if any differences in initial symptoms occur between HPV-positive and HPV-negative tumors. DESIGN, SETTING, AND PATIENTS Retrospective single-institution review of medical records of previously untreated patients with OPSCC diagnosed from January 1, 2008, toMay 20, 2013, who were evaluated by 1 physician (the senior author, T.A.D.) at the Medical University of South Carolina. MAIN OUTCOMES AND MEASURES We determined the most common initial symptoms of OPSCC and analyzed differences between HPV-positive and HPV-negative tumors. RESULTS Neck mass (in 39 patients [44%]) and sore throat (in 29 patients [33%]) comprised the most common initial symptoms in OPSCC. Patients who were HPV-positive were more likely to initially notice a neck mass than HPV-negative patients (51% vs 18%; P = .02), whereas HPV-negative patients were more likely to notice sore throat (53%vs 28%; P = .09), dysphagia (41% vs 10%; P = .05), or odynophagia (24%vs 6%; P = .04). CONCLUSIONS AND RELEVANCE This study provides preliminary evidence supporting neck mass and sore throat as the initial symptoms of patients with OPSCC. Patients who were HPV-positive more commonly complained of a neck mass as the initial symptom, whereas HPV-negative patients more commonly had symptoms related to the primary tumor site, including sore throat, dysphagia, and/or odynophagia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24652023     DOI: 10.1001/jamaoto.2014.141

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  22 in total

Review 1.  Morphologic diversity in human papillomavirus-related oropharyngeal squamous cell carcinoma: Catch Me If You Can!

Authors:  James S Lewis
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

2.  Inter- and intra-observer variability in the classification of extracapsular extension in p16 positive oropharyngeal squamous cell carcinoma nodal metastases.

Authors:  James S Lewis; Yaman Tarabishy; Jingqin Luo; Haresh Mani; Justin A Bishop; Marino E Leon; Manju L Prasad; Haodong Xu; Silvana Di Palma
Journal:  Oral Oncol       Date:  2015-08-17       Impact factor: 5.337

3.  Clinical and Molecular Characterization of Surgically Treated Oropharynx Squamous Cell Carcinoma Samples.

Authors:  Ana Carolina de Carvalho; Matias Eliseo Melendez; Cristina da Silva Sabato; Edenir Inez Palmero; Lidia Maria Rebolho Batista Arantes; Cristovam Scapulatempo Neto; André Lopes Carvalho
Journal:  Pathol Oncol Res       Date:  2018-08-11       Impact factor: 3.201

4.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What Is New in the 2017 WHO Blue Book for Tumors and Tumor-Like Lesions of the Neck and Lymph Nodes.

Authors:  Nora Katabi; James S Lewis
Journal:  Head Neck Pathol       Date:  2017-02-28

5.  Weight loss as a prognostic factor for recurrence and survival in oropharyngeal squamous cell carcinoma patients.

Authors:  Antuani Rafael Baptistella; Klisman Drescher Hilleshein; Caroline Beal; Juliana S Brambatti; Ruggero Caron; Shaline Ferla Baptistella; Radamés Ádamo Zuquello; Carina Rossoni; Gabriel Manfro
Journal:  Mol Clin Oncol       Date:  2018-10-05

6.  From presumed benign neck masses to delayed recognition of human papillomavirus-positive oropharyngeal cancer.

Authors:  Ruth J Davis; Eleni Rettig; Nafi Aygun; Lisa Rooper; Gypsyamber D'Souza; David W Eisele; Carole Fakhry
Journal:  Laryngoscope       Date:  2019-04-05       Impact factor: 3.325

Review 7.  HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.

Authors:  Mary Roz Timbang; Michael W Sim; Arnaud F Bewley; D Gregory Farwell; Avinash Mantravadi; Michael G Moore
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

8.  Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.

Authors:  Timo Carpén; Kauko Saarilahti; Caj Haglund; Antti Markkola; Jussi Tarkkanen; Jaana Hagström; Petri Mattila; Antti Mäkitie
Journal:  Strahlenther Onkol       Date:  2018-05-17       Impact factor: 3.621

9.  Morbidity, mortality and cost from HPV-related oropharyngeal cancer: Impact of 2-, 4- and 9-valent vaccines.

Authors:  Greg Ward; Vikas Mehta; Michael Moore
Journal:  Hum Vaccin Immunother       Date:  2015-11-13       Impact factor: 3.452

Review 10.  What pain tells us about cancer.

Authors:  Brian L Schmidt
Journal:  Pain       Date:  2015-04       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.